The Swiss Federal Council is set to vote on Wednesday, April 22, on new capital rules that could force UBS to find an additional $22 billion. This looming decision has prompted stark warnings from the bank’s leadership, with Chairman Colm Kelleher using the recent annual general meeting to criticize the proposals as a threat to its business model that offers little improvement to financial stability.
Analysts at Bank of America suggest there may be room for a compromise. Their base-case scenario anticipates that Bern will allow deferred tax assets from temporary differences to be counted as Common Equity Tier 1 (CET1) capital, up to a limit of 10%, aligning with Basel III standards. This adjustment would reduce the estimated capital burden from intangible assets to approximately $6.2 billion, a significant drop from the current projection of $10.8 billion.
A pivotal week for shareholders and strategy
This regulatory uncertainty unfolds during a critical period for the bank’s investors. Tuesday, April 21, marked the last day to trade UBS shares with the right to receive the 2025 dividend. The stock will trade ex-dividend from Wednesday, with a payout of $1.10 per share scheduled for April 23. Shareholders overwhelmingly approved this distribution at the AGM on April 15.
The immediate financial impact of the capital rules is severe. If the Federal Council’s original stance holds, Swiss banks would be forced to exclude items like banking software and deferred tax assets from their CET1 calculations starting in early 2027. For UBS, this would push its core capital ratio from 14.4% to 18.5%, requiring the bank to build a massive new buffer.
Political and economic pushback emerges
Should investors sell immediately? Or is it worth buying UBS?
Political support for diluting the proposals appears to be growing. According to a Financial Times report, parliamentarians from various parties have privately assured UBS executives they will work to soften the finance department’s plans. A parliamentary debate focusing on the treatment of foreign subsidiaries is scheduled for May 4.
The potential economic fallout extends beyond the bank’s balance sheet. A study commissioned by UBS from the BAK Economics research institute warns that fully capitalizing foreign subsidiaries could reduce Swiss GDP by a cumulative 11 to 34 billion Swiss francs over a decade.
Contrasting signals from the market
Amid this regulatory pressure, UBS received a vote of confidence from Fitch Ratings. The agency upgraded the long-term issuer default rating of UBS Group from ‘A’ to ‘A+’ with a stable outlook. Fitch cited progressing integration of Credit Suisse and the overcoming of major execution risks, expecting UBS to restore profitability to pre-acquisition levels by 2026. This upgrade offers a crucial counter-narrative and could lower future funding costs just as new capital requirements may pressure the cost structure.
All eyes now turn to the bank’s first-quarter 2026 results, due on April 29. Market observers will scrutinize the progress on cost synergies from the Credit Suisse integration and assess how management frames its outlook in light of the regulatory uncertainty. The Federal Council’s decision will directly shape market expectations for these figures and set the tone for the parliamentary debate to follow.
Ad
UBS Stock: Buy or Sell?! New UBS Analysis from April 20 delivers the answer:
The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 20.
UBS: Buy or sell? Read more here...
